XP Chemistries AB (XPC) AI Stock Analysis

• Market Cap: kr58.87M
• Dividend Yield: N/A
• Average Volume (3M): 792.79K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.65
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: SE
• Employees: 2
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): N/A
• Shares Outstanding: 313,976,300
• 10 Day Avg. Volume: 516,841
• 30 Day Avg. Volume: 792,795
• PEG Ratio: 0.11
• Price to Book (P/B): 0.97
• Price to Sales (P/S): 109.05
• P/FCF Ratio: -3.89
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): -0.02
• Revenue Forecast (FY): kr10.26M

• Rating: 47 Neutral
• Price Target: kr0.18 ▲(2.22% Upside)
• Action: Reiterated Date: 04/03/26
• Date: Action: Reiterated 04/03/26

The score is primarily held down by weak financial performance—structural unprofitability and ongoing cash burn—despite the offsetting benefit of a debt-free balance sheet. Technicals are neutral with limited momentum, and valuation signals are not informative given the provided P/E and missing dividend yield.

Positive Factors

Debt-free balance sheet

A zero-debt balance sheet provides durable financial flexibility and materially lowers refinancing and interest risks. Over a 2–6 month horizon this reduces bankruptcy risk and gives management room to fund operations or restructure without immediate external debt, supporting survival while seeking profitability.

Negative Factors

Persistent operating losses

Large, recurring operating and net losses indicate the core business model is not yet profitable. Over a multi-month horizon this requires continuous funding, inhibits reinvestment returns, and makes achievement of durable margins uncertain without structural changes to revenue or cost base.

XP Chemistries AB Business Overview & Revenue Model

Company Description

XP Chemistries AB, a biotechnology company, develops and produces forest-based capsaicin and analogues. It offers animal feed ingredients, cosmetic ingredients, pure capsaicinoids, and self-defense liquid and ingredients. The company was incorpora...

Read more

XP Chemistries AB, a biotechnology company, develops and produces forest-based capsaicin and analogues. It offers animal feed ingredients, cosmetic ingredients, pure capsaicinoids, and self-defense liquid and ingredients. The company was incorpora...

How the Company Makes Money

null...

XP Chemistries AB Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	327.39K	283.94K	663.68K	1.06M	279.39K
Gross Profit	127.68K	328.97K	335.61K	488.98K	149.56K
EBITDA	-9.05M	-7.52M	-8.70M	-8.73M	-5.01M
Net Income	-8.52M	-7.13M	-8.04M	-7.92M	-4.55M
Balance Sheet
Total Assets	38.07M	22.72M	27.20M	30.65M	34.39M
Cash, Cash Equivalents and Short-Term Investments	15.23M	2.15M	7.83M	15.20M	21.40M
Total Debt	0.00	0.00	0.00	0.00	0.00
Total Liabilities	1.13M	1.16M	1.51M	1.58M	3.09M
Stockholders Equity	36.94M	21.56M	25.69M	29.07M	31.30M
Cash Flow
Free Cash Flow	-9.18M	-8.53M	-11.41M	-11.80M	-8.13M
Operating Cash Flow	-8.85M	-7.69M	-9.08M	-9.85M	-4.99M
Investing Cash Flow	-332.30K	-834.96K	-2.33M	-1.95M	-6.31M
Financing Cash Flow	22.26M	2.85M	4.04M	5.60M	32.70M

XP Chemistries AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
XPC	47 Neutral	kr58.87M	-4.19	―	―	―	―